发文地区与机构
近年国家 / 地区发文量统计
| 国家 / 地区 | 发文量 |
|---|---|
| USA | 578 |
| England | 255 |
| Denmark | 185 |
| GERMANY (FED REP GER) | 183 |
| Italy | 168 |
| Spain | 110 |
| Switzerland | 89 |
| Netherlands | 86 |
| Taiwan | 50 |
| France | 48 |
近年机构发文量统计
| 机构 | 发文量 |
|---|---|
| UNIVERSITY OF LONDON | 131 |
| UNIVERSITY OF COPENHAGEN | 110 |
| MAYO CLINIC | 100 |
| YESHIVA UNIVERSITY | 95 |
| NOVARTIS | 79 |
| ELI LILLY | 63 |
| ABBVIE | 57 |
| HARVARD UNIVERSITY | 56 |
| RIGSHOSPITALET | 50 |
| LEIDEN UNIVERSITY | 46 |
文章引用情况
1
CGRP receptor antagonist MK-8825 attenuates cortical spreading depression induced pain behavior2
Molecular studies of CGRP and the CGRP family of peptides in the central nervous system3
When migraine mimics stroke: A systematic review4
Interim results of a prospective, randomized, open-label, Phase 3 study of the long-term safety and efficacy of lasmiditan for acute treatment of migraine (the GLADIATOR study)5
Gender aspects of CGRP in migraine6
Cost-effectiveness analysis of erenumab for the preventive treatment of episodic and chronic migraine: Results from the US societal and payer perspectives7
The effects of aerobic exercise for persons with migraine and co-existing tension-type headache and neck pain. A randomized, controlled, clinical trial8
Lifestyle factors and risk of migraine and tension-type headache. Follow-up data from the Nord-Trondelag Health Surveys 1995-1997 and 2006-20089
A phase 1 study to assess the pharmacokinetics, safety, and tolerability of fremanezumab doses (225 mg, 675 mg and 900 mg) in Japanese and Caucasian healthy subjects10
Correlation between nerve atrophy, brain grey matter volume and pain severity in patients with primary trigeminal neuralgia